Literature DB >> 3804892

Impact of orally administered antimicrobial agents on human oropharyngeal and colonic microflora.

C E Nord, A Heimdahl.   

Abstract

Phenoxymethylpenicillin, bacampicillin, clindamycin, erythromycin and doxycycline were given orally to 46 subjects for seven days. The numbers of aerobic and anaerobic bacteria in the oropharyngeal and colonic microflora were determined as were the concentrations of antimicrobial agents in saliva and faeces. Clindamycin, erythromycin and doxycycline were detected both in saliva and faeces. Phenoxymethylpenicillin, bacampicillin and doxycycline caused only minor changes in the microflora, while pronounced suppression of anaerobic bacteria was noticed when clindamycin was administered. Erythromycin decreased the aerobic bacteria in the oropharynx and both aerobic and anaerobic bacteria in the colon. New colonizing clostridia, enterobacteria and fungi were found both in the oropharynx and in the colon when erythromycin and clindamycin were administered.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3804892     DOI: 10.1093/jac/18.supplement_c.159

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  P1A recombinant beta-lactamase prevents emergence of antimicrobial resistance in gut microflora of healthy subjects during intravenous administration of ampicillin.

Authors:  Ann-Mari Tarkkanen; Tuula Heinonen; Rain Jõgi; Silja Mentula; Michel E van der Rest; Curtis J Donskey; Tuomas Kemppainen; Konstantin Gurbanov; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

2.  Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?

Authors:  Dongyan Xu; Thriveen S C Mana; Jennifer L Cadnum; Abhishek Deshpande; Faezeh Afsari; Naseer Sangwan; Curtis J Donskey
Journal:  Pathog Immun       Date:  2022-06-21

3.  Profiling the Effects of Systemic Antibiotics for Acne, Including the Narrow-Spectrum Antibiotic Sarecycline, on the Human Gut Microbiota.

Authors:  Ines B Moura; Ayman Grada; William Spittal; Emma Clark; Duncan Ewin; James Altringham; Emilio Fumero; Mark H Wilcox; Anthony M Buckley
Journal:  Front Microbiol       Date:  2022-05-31       Impact factor: 6.064

4.  Orally administered targeted recombinant Beta-lactamase prevents ampicillin-induced selective pressure on the gut microbiota: a novel approach to reducing antimicrobial resistance.

Authors:  Jaana Harmoinen; Silja Mentula; Matti Heikkilä; Michel van der Rest; Päivi J Rajala-Schultz; Curtis J Donskey; Rafael Frias; Pertti Koski; Nina Wickstrand; Hannele Jousimies-Somer; Elias Westermarck; Kai Lindevall
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

Review 5.  Potential role of periodontal infection in respiratory diseases - a review.

Authors:  M Bansal; M Khatri; V Taneja
Journal:  J Med Life       Date:  2013-09-25

6.  Role of Short Chain Fatty Acids in Controlling Tregs and Immunopathology During Mucosal Infection.

Authors:  Natarajan Bhaskaran; Cheriese Quigley; Clarissa Paw; Shivani Butala; Elizabeth Schneider; Pushpa Pandiyan
Journal:  Front Microbiol       Date:  2018-08-24       Impact factor: 5.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.